scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JTHO.2016.03.021 |
P698 | PubMed publication ID | 27103512 |
P2093 | author name string | Jon Cacicedo | |
Arturo Navarro-Martin | |||
Ferran Guedea | |||
Valentin Navarro | |||
Ricard Ramos | |||
Maria Arnaiz | |||
Samantha Aso | |||
Rodolfo de Blas | |||
Samuel Rosales | |||
P433 | issue | 7 | |
P921 | main subject | phase II clinical trial | Q42824440 |
P304 | page(s) | 1101-1111 | |
P577 | publication date | 2016-04-18 | |
P1433 | published in | Journal of Thoracic Oncology | Q2448056 |
P1476 | title | Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months. | |
P478 | volume | 11 |
Q38790915 | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer |
Q36382039 | Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis |
Q90095163 | Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer |
Q64969902 | Early stage lung cancer survival after wedge resection and stereotactic body radiation. |
Q89572724 | Feasibility of stereotactic radiotherapy for lung lesions and conventional radiotherapy for nodal areas in primary lung malignancies |
Q49244538 | Helical Therapy is Safe for Lung Stereotactic Body Radiation Therapy Despite Limitations in Achieving Sharp Dose Gradients |
Q42154657 | Parenchymal and Functional Lung Changes after Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer-Experiences from a Single Institution |
Q58801338 | Real-world treatment patterns for patients 80 years and older with early lung cancer: a nationwide claims study |
Q89932945 | Single-lung stereotactic body radiotherapy: A case report and discussion of therapeutic challenges |
Q60912983 | Stereotactic body radiation therapy for non-small cell lung cancer: A review |
Q47108053 | Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience |
Q48238743 | The TNM 8 M1b and M1c classification for non-small cell lung cancer in a cohort of patients with brain metastases |
Search more.